FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q38811164> ?p ?o ?g. }

• Q38811164 description "2017 nî lūn-bûn" @default.
• Q38811164 description "2017年の論文" @default.
• Q38811164 description "2017年論文" @default.
• Q38811164 description "2017年論文" @default.
• Q38811164 description "2017年論文" @default.
• Q38811164 description "2017年論文" @default.
• Q38811164 description "2017年論文" @default.
• Q38811164 description "2017年论文" @default.
• Q38811164 description "2017年论文" @default.
• Q38811164 description "2017年论文" @default.
• Q38811164 description "2017年论文" @default.
• Q38811164 description "2017年论文" @default.
• Q38811164 description "2017年论文" @default.
• Q38811164 description "2017년 논문" @default.
• Q38811164 description "article científic" @default.
• Q38811164 description "article scientific" @default.
• Q38811164 description "article scientifique" @default.
• Q38811164 description "articol științific" @default.
• Q38811164 description "articolo scientifico" @default.
• Q38811164 description "artigo científico" @default.
• Q38811164 description "artigo científico" @default.
• Q38811164 description "artigo científico" @default.
• Q38811164 description "artikel ilmiah" @default.
• Q38811164 description "artikull shkencor" @default.
• Q38811164 description "artikulong pang-agham" @default.
• Q38811164 description "artykuł naukowy" @default.
• Q38811164 description "artículo científico publicado en 2017" @default.
• Q38811164 description "artículu científicu espublizáu en 2017" @default.
• Q38811164 description "bilimsel makale" @default.
• Q38811164 description "bài báo khoa học" @default.
• Q38811164 description "naučni članak" @default.
• Q38811164 description "scienca artikolo" @default.
• Q38811164 description "scientific article published on May 2017" @default.
• Q38811164 description "scientific article published on May 2017" @default.
• Q38811164 description "scientific article published on May 2017" @default.
• Q38811164 description "teaduslik artikkel" @default.
• Q38811164 description "tieteellinen artikkeli" @default.
• Q38811164 description "tudományos cikk" @default.
• Q38811164 description "vedecký článok" @default.
• Q38811164 description "vetenskaplig artikel" @default.
• Q38811164 description "videnskabelig artikel" @default.
• Q38811164 description "vitenskapelig artikkel" @default.
• Q38811164 description "vitskapeleg artikkel" @default.
• Q38811164 description "vědecký článek" @default.
• Q38811164 description "wetenschappelijk artikel" @default.
• Q38811164 description "wissenschaftlicher Artikel" @default.
• Q38811164 description "επιστημονικό άρθρο" @default.
• Q38811164 description "мақолаи илмӣ" @default.
• Q38811164 description "наукова стаття, опублікована в травні 2017" @default.
• Q38811164 description "научна статия" @default.
• Q38811164 description "научная статья" @default.
• Q38811164 description "научни чланак" @default.
• Q38811164 description "научни чланак" @default.
• Q38811164 description "מאמר מדעי" @default.
• Q38811164 description "مقالة علمية نشرت في مايو 2017" @default.
• Q38811164 description "মে ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q38811164 description "บทความทางวิทยาศาสตร์" @default.
• Q38811164 description "სამეცნიერო სტატია" @default.
• Q38811164 name "A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a S" @default.
• Q38811164 name "A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a S" @default.
• Q38811164 name "A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a S" @default.
• Q38811164 type Item @default.
• Q38811164 label "A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a S" @default.
• Q38811164 label "A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a S" @default.
• Q38811164 label "A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a S" @default.
• Q38811164 prefLabel "A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a S" @default.
• Q38811164 prefLabel "A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a S" @default.
• Q38811164 prefLabel "A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a S" @default.
• Q38811164 P1433 Q38811164-A314795B-C805-451E-9D98-BF0352C6945B @default.
• Q38811164 P1476 Q38811164-848CD732-FEBF-4B24-A81F-0B1CBF7BF60C @default.
• Q38811164 P2093 Q38811164-54B981CF-F451-4C1F-89D5-1D954502C8DE @default.
• Q38811164 P2093 Q38811164-6AFAF4C5-84CC-4DCB-BD6C-5405F293FC0E @default.
• Q38811164 P2093 Q38811164-6CA35544-1657-4979-8DE9-9F0DE848DB12 @default.
• Q38811164 P2093 Q38811164-7F3335DB-6282-400E-A4E5-BCA82895FA7E @default.
• Q38811164 P2093 Q38811164-8C0C3478-DE4F-41D5-9C99-150152E51B2A @default.
• Q38811164 P2093 Q38811164-947C8ACC-9776-492B-ADE3-1E7476131EEE @default.
• Q38811164 P2093 Q38811164-A707878E-360F-4F7D-B893-C9EA835EF8C9 @default.
• Q38811164 P2093 Q38811164-AA8FCC3D-7EA3-4816-96C9-7213A0D9E993 @default.
• Q38811164 P2093 Q38811164-C6D78379-0D39-4482-B791-59D9BA505406 @default.
• Q38811164 P2093 Q38811164-DFCE1289-880B-47CF-8B81-FAFF3E977F0D @default.
• Q38811164 P2093 Q38811164-EEB1F0E0-A5CA-45DE-A7B2-ADA08F61B4FE @default.
• Q38811164 P304 Q38811164-5DE2263F-5964-4693-8E16-F040BBABADF9 @default.
• Q38811164 P31 Q38811164-9FE78CA5-4701-4911-A80A-C4377E6F7F55 @default.
• Q38811164 P356 Q38811164-87383EC5-FB9E-46A0-B030-7D27D531296F @default.
• Q38811164 P407 Q38811164-8548CCDC-3744-45DB-8B23-60D325C19153 @default.
• Q38811164 P433 Q38811164-D512F3E3-2B30-4ABF-A980-087588E6E71C @default.
• Q38811164 P478 Q38811164-39D18AE1-DFC0-4FC8-82CE-231FEDC5F0E4 @default.
• Q38811164 P577 Q38811164-D15F9A17-30B2-435F-B842-11343ABFA328 @default.
• Q38811164 P698 Q38811164-18C82605-75E9-4F82-A16A-FA558C5E752C @default.
• Q38811164 P921 Q38811164-036AB4A7-16B5-4465-9A27-40C909510DE6 @default.
• Q38811164 P921 Q38811164-1A20E5D3-ABB1-42F3-A21A-A5AD4E113050 @default.
• Q38811164 P356 ALN.0000000000001662 @default.
• Q38811164 P698 28459733 @default.
• Q38811164 P1433 Q2012635 @default.
• Q38811164 P1476 "A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a S" @default.
• Q38811164 P2093 "Anthony R Absalom" @default.
• Q38811164 P2093 "Beatrijs I Valk" @default.
• Q38811164 P2093 "Douglas J Eleveld" @default.
• Q38811164 P2093 "Izaak den Daas" @default.
• Q38811164 P2093 "Jason A Campagna" @default.

• next